John Hornberger, MD, MS, FACP
CEO, President

Dr. Hornberger is a clinical investigator whose research focuses on clinical outcomes and associated ethical and economic implications of novel health technologies, including drugs, molecular diagnostics, and devices. He has been Principal Investigator for clinical trials, clinical registries and large databases; his research applies state-of-the-art methods in biostatistics, epidemiology, clinical trial design, meta-analysis, and decision analysis. He has published on technologies for cancer, diabetes, rheumatic diseases, mental health, infectious diseases (HIV, hepatitis, and herpes zoster), care for the poor and underserved, and others. He has published seminal papers on the evaluation of genomic assays, clinical utility studies, and on the cost-effectiveness of specific assays. His research is published in leading clinical and policy journals (e.g. Journal of the National Cancer Institute, Annals of Internal Medicine, JAMA) and his work is cited in international appraisals of new cancer technologies, such as the UK National Institute of Clinical Excellence and the Canadian Coordinating Office for Health Technology Assessment.

At Cedar Associates Dr. Hornberger has provided Chief Medical Officer (CMO) consulting services, contributing to the strategy, development and implementation of innovative clinical programs/study designs that include collaboration with strategic business partners and academic institutes.

Dr. Hornberger is Adjunct Clinical Professor of Medicine at Stanford University School of Medicine, supervising resident house staff in a clinic devoted to the care of the poor and underserved. He received his M.D. degree from the University of Rochester, New York and M.S. degree in Health Services Research from Stanford University. He is past Co-Editor of Value in Health and is on the Editorial Board of Medical Decision Making. He is member of the ASCO Ethics Committee examining the bioethical implications of precision medicine. Also, he is currently working with the Department of Veterans Affairs on bioethical and scientific principles of evolving Learning Healthcare Systems. He has served on various NIH scientific and economic advisory committees.

Professional Talks